You are here: Industry Insights > antibody therapeutics

News List

Boan Biotech Publishes Research Results for CEA/CD3 Bispecific Antibody in Antibody Therapeutics prnasia
June 25, 2021
Luye Pharma Group's subsidiary Boan Biotech recently published research results for its innovative in-house bispecific antibody BA1202 (CEA/CD3 bispecific T-cell engager) in Antibody Therapeutics.
AbbVie inks $750m cancer therapeutics deal with Genmab pharmaceutical-technology
June 15, 2020
AbbVie has entered a collaboration agreement with biotechnology company Genmab to develop and commercialise antibody therapeutics for cancer.
Sanofi and Biomunex partner to develop antibody therapeutics pharmaceutical-technology
January 17, 2019
Sanofi has signed a licensing agreement with French biopharmaceutical firm Biomunex Pharmaceuticals for the development of antibody-based drugs.....
Gritstone ramps up bispecifics with new antibody therapeutics chief fiercebiotech
December 28, 2018
Gritstone Oncology has appointed Jonah Rainey, Ph.D., to head up its bispecific antibody program as it moves into lead optimization.....
WuXi Biologics, ABL Bio Enter Development Deal contractpharma
November 30, 2018
WuXi Biologics and ABL Bio Corporation have entered into an exclusive development and clinical manufacturing partnership for up to 8 antibody therapeutics including ABL Bio’s biologics pipelines and collaboration programs between...